-
Part 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns
-
Part 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp
-
Part 3 | Session 7 SGLT2 is Associated with Reduction in Atrial-Arrythmic Events
-
Part 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes
-
Part 3 | Session 11 SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM
-
Part 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial
-
Part 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial
-
Part 1 | Session 3 AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study
-
Part 3 | Session 1 Population Strategies for the Management of Hypertension
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Late-breaker Discussion Series
Part 2
View from the Thoraxcenter: Preview of the Late-Breaking Trials
Part 3
Expert Interviews
Faculty Biographies
Stephen Nicholls
Monash Victorian Heart Institute Director and Professor of Cardiology
Prof Stephen Nicholls is the Director of the Monash Victorian Heart Institute in Melbourne, AU and a Professor of Cardiology at Monash University. He also serves as the Deputy Director and Heart Health Theme Leader at the South Australian Health and Medical Research Institute, Adelaide, AU.
Prof Nicholls completed his cardiology training at the John Hunter Hospital and received his Doctor of Philosophy (PhD) in Medical Biochemistry from the University of Adelaide.
He has written over 770 manuscripts, book chapters and conference proceedings. His research is focused on strategies to reduce the risk of heart disease, novel vascular imaging and generating an understanding of the factors that promote plaque formation. He has raised over $100 million in research funding and has received multiple awards, including the Cleveland Clinic Innovator Award in 2011, the NHMRC Research Excellence Award in 2016, the RT Hall Price in 2018 and the Eric Susman Prize in…